Daniel Muthas

2.7k citations

33 papers · 863 indexed · h-index 16

Impact in

Computational Theory and Mathematics top 5%
- Computational Drug Discovery Methods
Immunology
- IL-33, ST2, and ILC Pathways

Papers in ⓘ

Aging 1
Pharmacology 4

Co-authors: Anders Karlén (8 shared papers)Scott Boyer (3 shared papers)Yogesh Sabnis (2 shared papers)Aurijit Sarkar (1 shared paper)Ruth Brenk (1 shared paper)Stefan Schmitt (1 shared paper)Silvio Danese (1 shared paper)Mohib Uddin (1 shared paper)
Journals: Annals of the Rheumatic Diseases (3 papers)Respiratory Research (2 papers)MedChemComm (2 papers)Bioorganic & Medicinal Chemistry (2 papers)Journal of Peptide Science (2 papers)
Partner nations: Sweden United Kingdom United States

In The Last Decade

Daniel Muthas

33 papers receiving 840 citations

Peers

Countries citing papers authored by Daniel Muthas

Since Specialization

Citations

This map shows the geographic impact of Daniel Muthas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Muthas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Muthas more than expected).

Fields of papers citing papers by Daniel Muthas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Muthas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Muthas. The network helps show where Daniel Muthas may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel Muthas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Muthas Line = papers co-authored together Daniel Muthas links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications Scandinavian Journal of Gastroenterology ·Daniel Muthas, Anna Reznichenko, Clare A. Balendran, Gerhard Böttcher, Ib Groth Clausen, Carina Kärrman Mårdh, Tomas Ottosson, Mohib Uddin, Thomas T. MacDonald, Silvio Danese, Mark Berner Hansen	2016	141
2	Scope and Limitations of Baird's Theory on Triplet State Aromaticity: Application to the Tuning of Singlet–Triplet Energy Gaps in Fulvenes Chemistry - A European Journal ·Henrik Ottosson, Kristine Kilså, Khalil Chajara, M.C. Piqueras, R. Crespo, Haruhisa Kato, Daniel Muthas	2007	78
3	Functionalized 3-amino-imidazo[1,2-a]pyridines: A novel class of drug-like Mycobacterium tuberculosis glutamine synthetase inhibitors Bioorganic & Medicinal Chemistry Letters ·Luke R. Odell, Mikael Nilsson, Johan Gising, Olof Lagerlund, Daniel Muthas, Anneli Nordqvist, Anders Karlén, Mats Larhed	2009	78
4	Evaluation of the use of imaging parameters for the detection of compound-induced hepatotoxicity in 384-well cultures of HepG2 cells and cryopreserved primary human hepatocytes Toxicology in Vitro ·Helen Garside, Karen F. Marcoe, Jessica Chesnut-Speelman, Alison J. Foster, Daniel Muthas, J. Gerry Kenna, Usha Warrior, Joanne Bowes, James E. Baumgartner	2013	74
5	Activation of group 2 innate lymphoid cells after allergen challenge in asthmatic patients Journal of Allergy and Clinical Immunology ·Carla Winkler, Thomas Hochdörfer, Elisabeth Israelsson, Annemarie Hasselberg, Anders Cavallin, Kristofer Thörn, Daniel Muthas, Shervin Shojaee, Katrin Lüer, Meike Müller, Jenny Mjösberg, Outi Vaarala, Jens M. Hohlfeld, Katerina Pardali	2019	71
6	DrugPred: A Structure-Based Approach To Predict Protein Druggability Developed Using an Extensive Nonredundant Data Set Journal of Chemical Information and Modeling ·Agata Krasowski, Daniel Muthas, Aurijit Sarkar, Stefan Schmitt, Ruth Brenk	2011	68
7	Is it possible to increase hit rates in structure-based virtual screening by pharmacophore filtering? An investigation of the advantages and pitfalls of post-filtering Journal of Molecular Graphics and Modelling ·Daniel Muthas, Yogesh Sabnis, Magnus Lundborg, Anders Karlén	2007	47
8	Fungal Dysbiosis and Intestinal Inflammation in Children With Beta-Cell Autoimmunity Frontiers in Immunology ·Jarno Honkanen, Arja Vuorela, Daniel Muthas, L. Orivuori, Kristiina Luopajärvi, Mysore V. Tejesvi, Anton Lavrinienko, Anna Maria Pirttilä, Christopher L. Fogarty, Taina Härkönen, Jorma Ilonen, Terhi Ruohtula, Mikael Knip, Janne J. Koskimäki, Outi Vaarala	2020	34
9	Type I interferon blockade with anifrolumab in patients with systemic lupus erythematosus modulates key immunopathological pathways in a gene expression and proteomic analysis of two phase 3 trials Annals of the Rheumatic Diseases ·Tina Baker, Hoda Sharifian, Paul J. Newcombe, Patrick G. Gavin, Mark Lazarus, Madhu Ramaswamy, Wendy I. White, Nicola Ferrari, Daniel Muthas, Raj Tummala, Eric F. Morand, Richard Furie, Edward M Vital, Chris Chamberlain, Adam Platt, Hussein Al‐Mossawi, Philip Z. Brohawn, Eszter Csomor	2024	32
10	Synthesis, biological evaluation and X-ray crystallographic studies of imidazo[1,2-a]pyridine-based Mycobacterium tuberculosis glutamine synthetase inhibitors MedChemComm ·Anneli Nordqvist, Mikael Nilsson, Olof Lagerlund, Daniel Muthas, Johan Gising, Samir Yahiaoui, Luke R. Odell, B. R. Srinivasa, Mats Larhed, Sherry L. Mowbray, Anders Karlén	2012	31
11	A critical assessment of modeling safety-related drug attrition MedChemComm ·Daniel Muthas, Scott Boyer, Catrin Hasselgren	2013	31
12	Synthesis, biological evaluation, and modeling studies of inhibitors aimed at the malarial proteases plasmepsins I and II Bioorganic & Medicinal Chemistry ·Daniel Muthas, Daniel Nöteberg, Yogesh Sabnis, Elizabeth Hamelink, Lotta Vrang, Bertil Samuelsson, Anders Karlén, Anders Hallberg	2005	30
13	Design, synthesis and evaluation of peptide inhibitors of Mycobacterium tuberculosis ribonucleotide reductase Journal of Peptide Science ·Johanna Nurbo, A.K. Roos, Daniel Muthas, Erik Wahlström, Daniel J. Ericsson, Torbjörn Lundstedt, Torsten Unge, Anders Karlén	2007	24
14	Dysregulation of COVID-19 related gene expression in the COPD lung Respiratory Research ·(unknown), Alastair Watson, Lisa Öberg, B. Angermann, C. Mirella Spalluto, Michael Hühn, Hannah Burke, Doriana Cellura, Anna Freeman, Daniel Muthas, Damla Etal, Graham Belfield, Fredrik Karlsson, Karl Nordström, Kristoffer Ostridge, Karl J. Staples, Tom Wilkinson	2021	23
15	Bleomycin hydrolase regulates the release of chemokines important for inflammation and wound healing by keratinocytes Scientific Reports ·Rebecca Riise, Lina Odqvist, Johan Mattsson, Susan J. Monkley, Suado M. Abdillahi, Christian Tyrchan, Daniel Muthas, Linda Yrlid	2019	17
16	Application of Data Mining and Visualization Techniques for the Prediction of Drug-Induced Nausea in Man Toxicological Sciences ·Joanna Parkinson, Daniel Muthas, Matthew Clark, Scott Boyer, Jean‐Pierre Valentin, Lorna Ewart	2011	17
17	MODifieR: an Ensemble R Package for Inference of Disease Modules from Transcriptomics Networks Bioinformatics ·Hendrik Weerd, Tejaswi V. S. Badam, David Martínez-Enguita, Julia Åkesson, Daniel Muthas, Mika Gustafsson, Zelmina Lubovac-Pilav	2020	13
18	Exploiting Pharmacological Similarity to Identify Safety Concerns – Listen to What the Data Tells You Molecular Informatics ·Daniel Muthas, Scott Boyer	2013	11
19	Identification of small peptides mimicking the R2 C‐terminus of Mycobacterium tuberculosis ribonucleotide reductase Journal of Peptide Science ·Daniel J. Ericsson, Johanna Nurbo, Daniel Muthas, Kalle Hertzberg, Gunnar Lindeberg, Anders Karlén, Torsten Unge	2010	7
20	Novel pseudopeptides incorporating a benzodiazepine-based turn mimetic—targeting Mycobacterium tuberculosis ribonucleotide reductase Bioorganic & Medicinal Chemistry ·Johanna Nurbo, Daniel J. Ericsson, Ulrika Rosenström, Daniel Muthas, Anna Jansson, Gunnar Lindeberg, Torsten Unge, Anders Karlén	2013	7

About Daniel Muthas

Daniel Muthas is a scholar working on Aging, Pharmacology, Immunology, Computational Theory and Mathematics and Rheumatology, having authored 33 papers that have together received 863 indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (6 papers), IL-33, ST2, and ILC Pathways (6 papers), Cancer therapeutics and mechanisms (5 papers), Tuberculosis Research and Epidemiology (5 papers), Asthma and respiratory diseases (4 papers), Protein Structure and Dynamics (3 papers), Biochemical and Molecular Research (3 papers) and Eosinophilic Esophagitis (3 papers). The work is most often cited by research in Computational Theory and Mathematics (178 citations), Immunology (181 citations), Pharmacology (70 citations), Organic Chemistry (199 citations) and Infectious Diseases (88 citations). Daniel Muthas has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Anders Karlén, Scott Boyer, Yogesh Sabnis, Aurijit Sarkar, Ruth Brenk, Stefan Schmitt, Silvio Danese, Mohib Uddin, Luke R. Odell and Gerhard Böttcher. Their work appears in journals such as Annals of the Rheumatic Diseases, Respiratory Research, MedChemComm, Bioorganic & Medicinal Chemistry and Journal of Peptide Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact